Clinical Trial Update: A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer [NA]

View source ↗

Summary

A prospective, single-arm exploratory trial evaluating TAS-102 (trifluridine/tipiracil) in combination with apatinib as third-line therapy for advanced gastric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Anhui Provincial Cancer Hospital | Conditions: Advanced Gastric Cancer | NA | Status: NOT_YET_RECRUITING